DDW was delighted to work with CN Bio on an exclusive event which focused on novel approaches to human lung disease modelling. The free event took place on 29 March at 3pm. It covered: Accelerating the discovery of new therapeutics for treatment… Read More
Jeremiah McDole, Oncology Segment Manager of the Digital Biology Group at Bio-Rad Laboratories, discusses key trends and challenges on the topic of whether minimal residual disease testing can help more patients beat cancer. According to the International Agency for Research on Cancer, almost 10 million individuals died from cancer worldwide… Read More
Arctoris and Evariste Technologies have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC). Current treatment options Current treatment options for NSCLC are limited, especially in advanced stages. It has been shown that… Read More
Jeffrey Fisher, PhD, Senior Research Fellow at ScitoVation, has been awarded the 2022 Society of Toxicology Arnold J. Lehman Award for his career-long body of work on physiologically based pharmacokinetic (PBPK) and biologically based dose response (BBDR) modeling tools to improve risk assessment. Fisher’s accomplishments … Read More
In this article, Professor Zheng-Zhu (Principal Investigator and Director of Metabolomics Research Center at the Shanghai Institute of Organic Chemistry) and Lucy Woods (Business Unit Manager for Phenomics and Metabolomics at Bruker Daltonics), summarise the most important configurations and options for partnering IMS–MS with liquid chromatography (LC) and show how… Read More
AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. Successful proposals will secure fully funded postdoctoral research positions. The challenge The challenge, launched at EXPO 2020 Dubai, invites final year MD and/or PhD students and… Read More
News round-up by DDW’s Megan Thomas for 14-18 March, 2022 Research, trial results and breakthroughs in treatments continue to take the spotlight in the drug discovery industry this week. Here are five key news stories from this period. 1. Needle-free intranasal Covid-19 vaccine gets… Read More
PerkinElmer Informatics has announced version 21 of its ChemDraw software, which provides researchers with the ability to import, animate and share 3D chemical structures natively in the Microsoft PowerPoint application. Impact The key enhancement helps chemists create more intelligent research reports quickly and easily, improving… Read More
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted Mundipharma and Cidara Therapeutics’ rezafungin Promising Innovative Medicine (PIM) designation for the treatment of invasive candidiasis. Invasive candidiasis is a severe, life-threatening systemic Candida infection of the bloodstream and/or deep/visceral tissues. The criteria … Read More
Ilya Pharma, a clinical stage immunotherapy company, has closed a €8.5 million funding round, which will be used to advance the company’s portfolio of three first-in-class immunotherapies for skin and mucosal diseases. The portfolio The active portfolio includes ILP100-Topical for treatment surgical wounds in diabetic,… Read More
New research from the International Longevity Centre (ILC) in London, UK, finds that social media advertising can be a cost-effective way of engaging older people in deprived communities with vaccination. The approach In the past, researchers found that older people are less likely to use… Read More
DDW’s Megan Thomas attended a BioIVT event at Scale Space to see BioIVT’s new blood donor center, whilst enjoying life science networking opportunities afforded by One Nucleus. She comments on the facilities located on Imperial College London’s White City Campus. Having started my role at DDW during the height of… Read More
Cellular therapeutics like CAR-T have revolutionised cancer treatment and hold immense promise in other areas of unmet medical need. Developing a new therapeutic cell line is no small task and requires the design and tracking of molecular tools, viral vectors, pluripotent stem cells and more. With projects spanning weeks and… Read More
Oragenics has entered into an agreement with KBI Biopharma for the process transfer, process optimisation and cGMP manufacturing of the company’s intranasal vaccine candidate NT-CoV2-1, which is expressed in a proprietary CHO cell line. Background Oragenics previously demonstrated robust immune response and reduction of SARS-CoV-2… Read More
Thermo Fisher Scientific and Symphogen are continuing their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterisation of complex therapeutic proteins. Since the collaboration began in 2018, Symphogen has adopted instruments and software to improve data quality and processes… Read More
Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the life-limiting, rare disease mucopolysaccharidosis II (MPS II) (also known as Hunter syndrome). Occurring in around one in 100,0000–170,000 births, MPS II presents almost exclusively in males and has a major impact on the physical and… Read More
